Background Despite advances in clinical therapies and technologies, the prognosis for

Background Despite advances in clinical therapies and technologies, the prognosis for patients with gastric cancer is still poor. level of was detectable in 48 (44.86%) of the gastric cancer specimens, and correlated with poor prognosis. In addition, our study indicated that miR203 inhibits cell proliferation and invasion via directly targeting and suppressing the expression. MiR203… Continue reading Background Despite advances in clinical therapies and technologies, the prognosis for